| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.088 | 0.03 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.094 | 0.03 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.08 | 0.03 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.087 | 0.03 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.083 | 0.03 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | 0.1 | 0.03 |